Literature DB >> 6300885

Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro.

A Henderson, S Ripley, M Heller, E Kieff.   

Abstract

The Epstein-Barr virus (EBV) genome stably persists in latently infected Burkitt tumor cells and growth-transformed B lymphocytes. These cells usually contain multiple copies of episomal viral DNA. Cytological hybridization of recombinant viral DNA fragments to metaphase chromosomes of two latently infected cell lines demonstrates that viral DNA localizes to both chromatids of one homologue of chromosome 1 in Namalwa, a Burkitt tumor cell line, and to both chromatids of one homologue of chromosome 4 in IB4, a cell line with transformed growth properties in vitro. The site of chromosome association remains stable in a clone of IB4 cells. Probes from five separate regions of the EBV genome hybridize to the same chromosome regions. A previously undescribed achromatic site is identified within the region of EBV chromosome cytological hybridization. These observations suggest that most or all of the EBV genome is integrated into the chromosomal DNA of Namalwa and IB4 cells. Although the chromosomal sites of EBV DNA association are among those regions with homology to the EBV IR3 repeated DNA sequence, EBV IR3 did not mediate recombination between EBV and chromosomal DNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300885      PMCID: PMC393737          DOI: 10.1073/pnas.80.7.1987

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell line.

Authors:  A Adams; T Lindahl; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

4.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1972-08-09

5.  Latent DNA of Epstein-Barr virus: separation from high-molecular-weight cell DNA in a neutral glycerol gradient.

Authors:  A Tanaka; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

6.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

7.  Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells.

Authors:  H Zur Hausen; H Schulte-Holthausen
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

8.  Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.

Authors:  T Lindahl; G Klein; B M Reedman; B Johansson; S Singh
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

9.  Marker band in one chromosome 14 from Burkitt lymphomas.

Authors:  G Manolov; Y Manolova
Journal:  Nature       Date:  1972-05-05       Impact factor: 49.962

10.  DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma.

Authors:  M Nonoyama; C H Huang; J S Pagano; G Klein; S Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

View more
  68 in total

1.  Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.

Authors:  I Melcák; S Cermanová; K Jirsová; K Koberna; J Malínský; I Raska
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.

Authors:  M S Kang; S C Hung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

3.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

4.  Nuclear factor κB represses the expression of latent membrane protein 1 in Epstein-Barr virus transformed cells.

Authors:  Mingxia Cao; Qianli Wang; Amy Lingel; Luwen Zhang
Journal:  World J Virol       Date:  2014-11-12

5.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Chromosomal insertion of human papillomavirus 18 sequences in HeLa cells detected by nonisotopic in situ hybridization and reflection contrast microscopy.

Authors:  P F Ambros; H I Karlic
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

7.  Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.

Authors:  C G Teo; B E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Epstein-barr virus-induced changes in B-lymphocyte gene expression.

Authors:  Kara L Carter; Ellen Cahir-McFarland; Elliott Kieff
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats.

Authors:  Allison M Repic; Mingxia Shi; Rona S Scott; John W Sixbey
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.